Objective To investigate the impacts of clinical features, blood and biochemical parameters on survival of patients with pancreatic cancer. Methods Two hundred and four patients with pathologically performed pancreatic cancer were retrospectively analyzed. All patients were followed-up by means of phone. Results The survival rate of 204 patients with pancreatic cancer was 32.8% at 1-year, 13.7% at 3-year and 2.9% at 5-year, with medium survival time of 6.4 months. Univariate examination showed that the long survival time was found in patients with radical or palliate operation in comparison with those without (P<0.01). The factors that impacted on the survival times were high tumor marker, .high serum creatinine, high white blood cells, low hemoglobin and low albumin (P<0.01). Whereas the patients with high levels of ALT and AST had long survival time (P(0.05). COX regression analysis revealed that those with advanced stage, low albumin and high creatinine had short survival time(P<0.05). Conclusions Surgery, tumor stage, tumor marker, hemoglobin, white blood cell, albumin and creatinine are independent prognostic factors.

Objective To analyze the clinical data of male breast cancer (MBC),and investigate the clinical characteristics and factors potentialy affecting prognosis of male breast cancer. Methods A retrospective case-control study was performed on 17 MBC and 102 female breast cancer cases from January 1996 to 2008, treated in the hospital with pathologic proofs. Results MBC accounted for 1.15% (17/1473) of all cases. The initial visiting age was older, the time from the appearance of lump to the first doctor contact was longer, the positive rate of axiUary lymph node metastasis and local skin change incidence ratio was higher in the male group (P <0.05); there was no significant difference about overall 5-year disease-specific survival between the two groups (P >0.05), when tumor stages and nodal involvement were checked, Conclusion This study suggests that the two groups' prognosis is similar, the gender is uncertain prognostic factor.